Today: 10 June 2026
Browse Category

NYSE:KVUE 9 November 2025 - 21 January 2026

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue shares rose 0.6% to $17.31 in late-morning New York trading Tuesday as investors awaited a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal’s outcome remains uncertain amid ongoing litigation risks tied to Kenvue’s legacy products. ISS has backed the merger but flagged legal concerns. Kenvue’s virtual shareholder meeting is scheduled for 9:00 a.m. Eastern on Jan. 29.
20 January 2026
··
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson shares closed down 0.4% at $218.66 Friday ahead of the Martin Luther King Jr. Day market holiday. The S&P 500 health care sector fell 0.8%. J&J reports fourth-quarter results Wednesday, Jan. 21, with investors focused on earnings and 2026 guidance. The NYSE will reopen Tuesday after the holiday.
18 January 2026
·······
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue shares closed at $17.20 Friday, down 0.35%, ahead of a Jan. 29 shareholder vote on its sale to Kimberly-Clark. Proxy adviser ISS recommended investors back the deal but cited ongoing legal and market risks. Kenvue updated merger disclosures after lawsuits challenged the process. The offer values Kenvue at about $18.03 per share, a 4.6% premium to Friday’s close.
18 January 2026
··
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue shares rose 0.4% to $17.08 in mid-morning trading after Kimberly-Clark filed new deal documents with U.S. regulators. The stock remains about 5% below the value implied by the pending cash-and-stock takeover. Kenvue shareholders are set to vote on the deal Jan. 29. The transaction’s value fluctuates with Kimberly-Clark’s share price.
14 January 2026
···
Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

Kenvue shares rose 0.8% to $16.87 Thursday after law firm Kahn Swick & Foti said it is investigating the company’s pending sale to Kimberly-Clark. The offer values Kenvue at about $17.91 per share, a 6% premium to Thursday’s price. Shareholders are set to vote on the deal in late January. Kenvue also named Madhav Nayak as vice president and chief marketing officer for Asia-Pacific.
8 January 2026
··
Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

Kenvue shares closed December 24 at $17.21, up 1.12% in light holiday trading, as investors weigh Kimberly-Clark’s pending acquisition. The agreed deal values KVUE at about $18.28 per share based on current KMB prices, but the stock trades below that level amid regulatory, timing, and legal uncertainties. The transaction is expected to close in the second half of 2026.
25 December 2025
··
Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

A Baltimore jury ordered Johnson & Johnson and spinoff Kenvue to pay over $1.5 billion in a talc cancer case, with J&J saying it will appeal. Kenvue shares traded at $16.98, about $1.15 below the implied $18.12 merger value based on Kimberly-Clark’s price, reflecting deal risk. The acquisition is expected to close in the second half of 2026. J&J has said it will cover Kenvue’s talc liabilities.
23 December 2025
···
Kenvue Stock (KVUE) News Today: Deal Spread Math, Kimberly-Clark Vote Timeline, Tylenol Lawsuits, and Analyst Forecasts (Dec. 19, 2025)

Kenvue Stock (KVUE) News Today: Deal Spread Math, Kimberly-Clark Vote Timeline, Tylenol Lawsuits, and Analyst Forecasts (Dec. 19, 2025)

Kenvue shares closed at $17.10 on Dec. 19, 2025, down 1.04% amid heavy trading. Kimberly-Clark’s pending cash-and-stock acquisition values Kenvue at about $18.35 per share, based on current prices, leaving a deal spread of roughly 7%. The merger awaits shareholder and regulatory approval, with legal risks and earnings pressure influencing the stock.
19 December 2025
··
Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025)

Kenvue shares traded near $17.33 midday Monday, about 7% below the implied $18.59 value of Kimberly-Clark’s pending cash-and-stock offer. The gap reflects market uncertainty as the $48.7 billion deal awaits regulatory and shareholder approval, with closing expected in the second half of 2026. Kimberly-Clark shares stood at $103.15. New legal filings and shareholder law firm activity surfaced Monday.
15 December 2025
··
KVUE Stock Today (Nov. 22, 2025): Kenvue Rises as Kimberly‑Clark Deal, Dividend and Tylenol Ruling Shape Outlook

KVUE Stock Today (Nov. 22, 2025): Kenvue Rises as Kimberly‑Clark Deal, Dividend and Tylenol Ruling Shape Outlook

Kenvue shares closed at $16.64 in late Friday trading, up 3% on heavy volume, but still about 12% below the value implied by Kimberly-Clark’s takeover offer. The deal, announced November 3 and valued at $48–49 billion, would pay Kenvue holders $3.50 in cash plus 0.14625 KMB shares per KVUE share. Both boards approved the merger, expected to close in the second half of 2026.
22 November 2025
·
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

Kenvue shares traded near $16.13 midday, down 0.7%, after a U.S. appeals court signaled it may revive over 500 Tylenol-autism lawsuits. A Texas judge declined to block Kenvue’s $398 million dividend, which remains set for Nov. 26. The pending Kimberly-Clark deal implies $18.83 per share for KVUE, about 14% above its current price. Volume reached 21.1 million shares by 17:32 UTC.
18 November 2025
·····
1 2 3

Stock Market Today

  • Top ASX Penny Stocks to Watch in June 2026: Boom Logistics and Cogstate
    June 9, 2026, 10:32 PM EDT. Amid Australian market weakness and recession fears, ASX penny stocks offer growth potential. Boom Logistics (ASX:BOL), with a market cap of A$74.16 million, generates A$275.08 million from lifting solutions in mining and infrastructure. Despite recent negative earnings growth, forecasts project 20.96% annual growth and a strengthened financial position under new CFO Pieter Le Roux. Cogstate Limited, valued at A$442 million, specializes in digital brain health assessments, showing robust revenue and a 46.7% earnings increase last year. Debt-free with strong assets, Cogstate is expanding sales in Psychiatry and Narcolepsy sectors. These firms exemplify promising opportunities in smaller-cap ASX stocks with improving fundamentals and strategic advancements.

Latest articles

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

10 June 2026
U.S. stock futures fell after hours and oil rose as U.S. strikes on Iran fueled risk-off sentiment, deepening losses in tech shares and raising investor caution ahead of Wednesday’s key inflation report, with fears of Fed rate hikes and volatility from the upcoming SpaceX IPO adding pressure.
Keel Slides After $458 Million AI Data-Center Debt Deal Launch

Keel Slides After $458 Million AI Data-Center Debt Deal Launch

10 June 2026
Keel Infrastructure shares plunged 4.24% to $5.42 after closing a $458 million convertible debt sale, reviving investor fears of future dilution even as the company boosts funding for AI-focused data-center projects; shares slipped further to $5.32 after hours on more than double average volume, reflecting concerns over execution risks and the impact of new financing.
Super Micro sinks after $7B AI server plan; dilution a risk

Super Micro sinks after $7B AI server plan; dilution a risk

10 June 2026
Super Micro Computer plans to raise $7 billion through equity and equity-linked financing to fund soaring AI server orders, sending shares down about 9% in after-hours trading as investors focused on dilution risk; the company reported $39 billion in recent AI server orders, but noted these are not firm commitments and cited ongoing legal and regulatory risks.
American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

10 June 2026
American Airlines surged to $14.09, up 48.5 cents, after announcing a three-year sustainable aviation fuel deal with Google covering 35 million gallons, as investors focused on surging fuel costs that jumped 78% in April to $6.5 billion; the stock rose in line with airline peers amid a drop in crude prices, while American’s 2026 outlook remains pressured by higher fuel expenses and a narrowed profit forecast.
Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

10 June 2026
Nokia shares plunged 6.99% to 11.970 euros in Helsinki after reports of Nvidia’s push into future mobile-network tech raised fears over Nokia’s AI-driven growth story, with investors questioning whether Nokia can maintain its edge as competition intensifies and its forward P/E more than doubles this year.
Go toTop